AU642764B2 - Agent for preventing and treating hepatitis - Google Patents

Agent for preventing and treating hepatitis Download PDF

Info

Publication number
AU642764B2
AU642764B2 AU83173/91A AU8317391A AU642764B2 AU 642764 B2 AU642764 B2 AU 642764B2 AU 83173/91 A AU83173/91 A AU 83173/91A AU 8317391 A AU8317391 A AU 8317391A AU 642764 B2 AU642764 B2 AU 642764B2
Authority
AU
Australia
Prior art keywords
amino acid
acid sequence
derivative
asp
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU83173/91A
Other languages
English (en)
Other versions
AU8317391A (en
Inventor
Seiji Akamatsu
Yoshikatu Hirai
Takashi Kamogashira
Yoshihiro Masui
Satoru Nakai
Tsutomu Nishida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU8317391A publication Critical patent/AU8317391A/en
Application granted granted Critical
Publication of AU642764B2 publication Critical patent/AU642764B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU83173/91A 1990-08-10 1991-08-09 Agent for preventing and treating hepatitis Ceased AU642764B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2-212941 1990-08-10
JP21294190 1990-08-10

Publications (2)

Publication Number Publication Date
AU8317391A AU8317391A (en) 1992-03-02
AU642764B2 true AU642764B2 (en) 1993-10-28

Family

ID=16630833

Family Applications (1)

Application Number Title Priority Date Filing Date
AU83173/91A Ceased AU642764B2 (en) 1990-08-10 1991-08-09 Agent for preventing and treating hepatitis

Country Status (6)

Country Link
EP (1) EP0495131B1 (OSRAM)
KR (1) KR920702230A (OSRAM)
AU (1) AU642764B2 (OSRAM)
DE (1) DE69126116T2 (OSRAM)
TW (1) TW212760B (OSRAM)
WO (1) WO1992002236A1 (OSRAM)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
JP2591615B2 (ja) * 1986-03-14 1997-03-19 大塚製薬株式会社 インターロイキン−１β誘導体及び医薬
IL80005A (en) * 1986-09-10 1992-11-15 Yeda Res & Dev Compositions for modulating the effect of tnf and il-1
AU600306B2 (en) * 1986-09-12 1990-08-09 Rockefeller University, The Methods and agents for removing advanced glycosylation endproducts
KR960008010B1 (ko) * 1988-07-29 1996-06-19 오오쓰까세이야꾸 가부시끼가이샤 IL-1α 유도체 및 혈소판 감소증 치료 약제

Also Published As

Publication number Publication date
AU8317391A (en) 1992-03-02
DE69126116T2 (de) 1997-08-28
WO1992002236A1 (fr) 1992-02-20
TW212760B (OSRAM) 1993-09-11
EP0495131A4 (en) 1993-10-13
EP0495131A1 (en) 1992-07-22
DE69126116D1 (de) 1997-06-19
EP0495131B1 (en) 1997-05-14
KR920702230A (ko) 1992-09-03

Similar Documents

Publication Publication Date Title
US5342615A (en) Method for treating arthritis or inflammation with Il-1α or derivatives thereof
Heller et al. Purification and primary structure of two neuroactive peptides that cause bag cell afterdischarge and egg-laying in Aplysia
EP0257406B1 (en) Recombinant B-cell differentiation factor
EP0251037B1 (en) Novel human TNF polypeptide mutants and DNAs encoding said mutants
Niewiarowski et al. Identification and separation of secreted platelet proteins by isoelectric focusing. Evidence that low-affinity platelet factor 4 is converted to beta-thromboglobulin by limited proteolysis
EP0187991A2 (en) Antitumor active substance, process for preparing the same, drug containing the substance, gene coding for the substance, vector containing the gene and recombinant microorganism
US5723117A (en) Use of interleukin-1 (IL-1) to inhibit development of hepatitis
EP0176299B1 (en) Mutual separation of proteins
EP0146026A2 (en) DNA encoding rabbit TNF, vector having said DNA inserted thereinto, host transformed with said vector, rabbit TNF polypeptide, and process for production thereof
AU627480B2 (en) Il-1alpha derivatives and medicament for treating thrombocytopenia
Ernst et al. O–Glycosylation and Novel Processing Events During Secretion of α–Factor/GM–CSF Fusions by Saccharomyces cerevisiae
AU642764B2 (en) Agent for preventing and treating hepatitis
JPH0649656B2 (ja) 血小板減少症治療剤
JP2678689B2 (ja) 肝炎予防・治療剤
JP2574701B2 (ja) インターロイキンー１α誘導体遺伝子
KR960003376B1 (ko) 혈소판 감소증 치료 약제
AU595864B2 (en) Il-1 alpha derivatives and drugs
JPWO1992002236A1 (ja) 肝炎予防・治療剤
WO1994019462A1 (fr) Facteurs de croissance de la famille de l'harp, procede d'obtention et applications
WO1994003492A1 (en) Interleukin-6 variants and uses therefor
EP0178050A1 (en) Proteinaceous substance
EP0233578A2 (en) Polypeptide possessing interleukin-2 activities
Kato Characteristics of natural and recombinant human interleukin 2
JPH09100296A (ja) 蛋白質の相互分離方法
JPH07165792A (ja) 精製された蛋白質

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired